|
51
|
224
|
5a0qE |
Cryo-em reveals the conformation of a substrate analogue in the human 20s proteasome core |
|
97
|
301
|
5hiqA |
Crystal structure of pqs response protein pqse in complex with 2-(1h-pyrrol-1-yl)benzoic acid |
|
87
|
259
|
5b1uA |
Crystal structure of metallo-beta-lactamase smb-1 bound to hydrolyzed imipenem |
|
87
|
259
|
5axoA |
Crystal structure of metallo-beta-lactamase smb-1 bound to hydrolyzed meropenem |
|
112
|
312
|
4zvzA |
Co-crystal structures of pp5 in complex with 5-methyl-7-oxabicyclo[2.2.1]heptane-2,3-dicarboxylic acid |
|
88
|
259
|
5b15A |
Crystal structure of metallo-beta-lactamase smb-1 bound to hydrolyzed doripenem |
|
50
|
189
|
4zc6B |
Crystal structure of human ggt1 in complex with serine borate |
|
48
|
189
|
4zcgB |
Crystal structure of human ggt1 in complex with glutamate (with all atoms of glutamate) |
|
49
|
186
|
5gtuA |
Structural and mechanistic insights into regulation of the retromer coat by tbc1d5 |
|
84
|
259
|
5ayaA |
Crystal structure of metallo-beta-lactamase smb-1 bound to l-captopril |
|
85
|
259
|
5axrA |
Crystal structure of metallo-beta-lactamase smb-1 bound to 2-mercaptoethanesulfonate |
|
49
|
189
|
4zbkB |
Crystal structure of human ggt1 in complex with ggstop inhibitor |
|
61
|
195
|
5fg9J |
Yeast 20s proteasome beta2-t(-2)v mutant |
|
68
|
243
|
5fgaF |
Yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) |
|
67
|
240
|
5fgiC |
Yeast 20s proteasome beta1-t1a beta2-t1a double mutant in complex with carfilzomib |
|
62
|
241
|
5fhsG |
Yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) in complex with carfilzomib |
|
39
|
194
|
5fmgL |
Structure and function based design of plasmodium-selective proteasome inhibitors |
|
68
|
233
|
5fgaM |
Yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) |
|
67
|
212
|
5fghK |
Yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) in complex with mg132 |
|
56
|
204
|
5fghI |
Yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) in complex with mg132 |
|
65
|
242
|
5fgeD |
Yeast 20s proteasome beta5-h(-2)t-t1a double mutant in complex with carfilzomib |
|
60
|
196
|
5fg7N |
Yeast 20s proteasome beta2-t1a mutant |
|
63
|
241
|
5fgeG |
Yeast 20s proteasome beta5-h(-2)t-t1a double mutant in complex with carfilzomib |
|
58
|
222
|
5fgfH |
Yeast 20s proteasome beta5-h(-2)a-t1a-k81r triple mutant in complex with carfilzomib |
|
68
|
232
|
5fgiM |
Yeast 20s proteasome beta1-t1a beta2-t1a double mutant in complex with carfilzomib |
|
61
|
222
|
5fg7L |
Yeast 20s proteasome beta2-t1a mutant |
|
69
|
240
|
5fggC |
Yeast 20s proteasome beta5-l(-49s)_d17n double mutant in complex with carfilzomib |
|
60
|
222
|
5fggL |
Yeast 20s proteasome beta5-l(-49s)_d17n double mutant in complex with carfilzomib |
|
67
|
242
|
5fg9D |
Yeast 20s proteasome beta2-t(-2)v mutant |
|
39
|
205
|
5fmgM |
Structure and function based design of plasmodium-selective proteasome inhibitors |
|
60
|
196
|
5fgdN |
Yeast 20s proteasome beta5-h(-2)l-t1a double mutant in complex with carfilzomib |
|
60
|
196
|
5fgeN |
Yeast 20s proteasome beta5-h(-2)t-t1a double mutant in complex with carfilzomib |
|
62
|
195
|
5fggJ |
Yeast 20s proteasome beta5-l(-49s)_d17n double mutant in complex with carfilzomib |
|
34
|
247
|
5fmgH |
Structure and function based design of plasmodium-selective proteasome inhibitors |
|
69
|
240
|
5fgeC |
Yeast 20s proteasome beta5-h(-2)t-t1a double mutant in complex with carfilzomib |
|
59
|
222
|
5fghL |
Yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) in complex with mg132 |
|
59
|
222
|
5fgiL |
Yeast 20s proteasome beta1-t1a beta2-t1a double mutant in complex with carfilzomib |
|
62
|
228
|
5fg7H |
Yeast 20s proteasome beta2-t1a mutant |
|
71
|
233
|
5fg7M |
Yeast 20s proteasome beta2-t1a mutant |
|
62
|
222
|
5fgaL |
Yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) |
|
59
|
196
|
5fghN |
Yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) in complex with mg132 |
|
61
|
195
|
5fhsJ |
Yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) in complex with carfilzomib |
|
67
|
233
|
5fghM |
Yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) in complex with mg132 |
|
68
|
244
|
5fgdB |
Yeast 20s proteasome beta5-h(-2)l-t1a double mutant in complex with carfilzomib |
|
62
|
241
|
5fg9G |
Yeast 20s proteasome beta2-t(-2)v mutant |
|
57
|
226
|
5fgaH |
Yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) |
|
69
|
250
|
5fhsA |
Yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) in complex with carfilzomib |
|
72
|
240
|
5fg9C |
Yeast 20s proteasome beta2-t(-2)v mutant |
|
43
|
231
|
5fmgF |
Structure and function based design of plasmodium-selective proteasome inhibitors |
|
64
|
231
|
5fg9E |
Yeast 20s proteasome beta2-t(-2)v mutant |
